Form 8-K - Current report:
SEC Accession No. 0001144204-15-045561
Filing Date
2015-07-31
Accepted
2015-07-31 17:19:22
Documents
4
Period of Report
2015-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v416855_8-k.htm 8-K 18063
2 EXHIBIT 10.1 v416855_ex10-1.htm EX-10.1 10230
3 GRAPHIC image_001.jpg GRAPHIC 8190
4 GRAPHIC image_002.jpg GRAPHIC 9011
  Complete submission text file 0001144204-15-045561.txt   53710
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 151020210
SIC: 2834 Pharmaceutical Preparations